Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / CLASS A COMMON STOCK
-
Shares outstanding
-
117,557,908
-
Total 13F shares
-
86,176,546
-
Share change
-
+2,554,025
-
Total reported value
-
$3,140,500,591
-
Put/Call ratio
-
96%
-
Price per share
-
$36.44
-
Number of holders
-
247
-
Value change
-
+$101,949,071
-
Number of buys
-
129
-
Number of sells
-
106
Institutional Holders of 10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) as of Q4 2022
As of 31 Dec 2022,
10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) was held by
247 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
86,176,546 shares.
The largest 10 holders included
MORGAN STANLEY, BAILLIE GIFFORD & CO, VANGUARD GROUP INC, BlackRock Inc., ARK Investment Management LLC, SANDS CAPITAL MANAGEMENT, LLC, FMR LLC, SRS Investment Management, LLC, GENERATION INVESTMENT MANAGEMENT LLP, and Sumitomo Mitsui Trust Holdings, Inc..
This page lists
250
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.